Catherine Emmanuel
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, Cancer-related molecular mechanisms research, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group(2012)1,162 cited
- → ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer(2014)227 cited
- → Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53 -Mutant Tumors and Identifies NRAS as an Oncogenic Driver(2014)115 cited
- → Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer(2017)91 cited
- → ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas(2013)62 cited
- → MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome(2010)62 cited
- → Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance(2018)51 cited
- → Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis(2011)40 cited
- → Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer(2014)35 cited
- → SYNERGISTIC INDUCTION OF APOPTOSIS IN HUMAN ENDOTHELIAL CELLS BY TUMOUR NECROSIS FACTOR-α AND TRANSFORMING GROWTH FACTOR-β(2002)30 cited